This excerpt taken from the GILD 8-K filed Aug 27, 2009.
Item 8.01 Other Events.
On August 26, 2009, Kevin Young, Executive Vice President, Commercial Operations of Gilead Sciences, Inc., entered into a new stock trading plan under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended (the Exchange Act). Trading under the plan will commence in December 2009 and expire in December 2011 to the extent applicable trading criteria are satisfied.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.